Orthorebirth Co., Ltd.
ORTHOREBIRTH is a pioneering company in regenerative medicine, specializing in innovative synthetic bone-void-filling materials and microfiber technology. Their flagship product, ReBOSSIS, is a flexible, cottony artificial bone designed to promote bone regeneration and is used in orthopedic surgeries worldwide. The company is committed to advancing regenerative medicine through research, development, and strategic partnerships.
Industries
Nr. of Employees
small (1-50)
Orthorebirth Co., Ltd.
Georgetown, Texas, United States, North America
Products
Cottony bioabsorbable bone-void-filling material
Flexible, soft, cotton-like bone void filler intended to be bioabsorbed and gradually replaced by host bone; designed for adaptable handling and variable filling volumes for bone defects.
Microfiber-based stem cell culture and implantable sheet (research use)
Microfiber sheet for stem cell culture that accelerates cell proliferation and is designed to be implantable without removing the sheet; offered for research purposes.
Hybrid bone-regeneration composite (β-TCP-containing) — under development
Hybrid material combining microfiber scaffold and protein components with β-tricalcium phosphate aimed at promoting bone regeneration; described as a development-stage medicine.
Biomaterial-based local drug-delivery prototype
Concept and research prototypes where therapeutics are kneaded into cottony/microfibrous materials for local application to affected areas.
Cottony bioabsorbable bone-void-filling material
Flexible, soft, cotton-like bone void filler intended to be bioabsorbed and gradually replaced by host bone; designed for adaptable handling and variable filling volumes for bone defects.
Microfiber-based stem cell culture and implantable sheet (research use)
Microfiber sheet for stem cell culture that accelerates cell proliferation and is designed to be implantable without removing the sheet; offered for research purposes.
Hybrid bone-regeneration composite (β-TCP-containing) — under development
Hybrid material combining microfiber scaffold and protein components with β-tricalcium phosphate aimed at promoting bone regeneration; described as a development-stage medicine.
Biomaterial-based local drug-delivery prototype
Concept and research prototypes where therapeutics are kneaded into cottony/microfibrous materials for local application to affected areas.
Services
Collaborative research and development partnerships
Joint R&D projects with universities and institutions including subsidized development work and technology transfer for regenerative-medicine products.
Sales and distribution of medical materials
Commercial distribution and market-entry support for absorbable biomaterial products across territories.
Collaborative research and development partnerships
Joint R&D projects with universities and institutions including subsidized development work and technology transfer for regenerative-medicine products.
Sales and distribution of medical materials
Commercial distribution and market-entry support for absorbable biomaterial products across territories.
Expertise Areas
- Regenerative medicine
- Biomaterials and scaffold engineering
- Bone graft substitute development
- Cell culture technologies for implantation
Key Technologies
- Microfiber fabrication for biomaterials
- Bioabsorbable scaffold engineering
- Beta-tricalcium phosphate (β-TCP) composites
- Implantable cell-culture sheets